期刊文献+

慢性阻塞性肺疾病稳定期中医证型与红细胞免疫功能的相关性 被引量:6

Correlation between Erythrocyte Immune Function and TCM Syndromes of COPD Patients at Stable Stage
暂未订购
导出
摘要 目的研究慢性阻塞性肺疾病稳定期中医证型与红细胞免疫功能的相关性。方法按《慢性阻塞性肺疾病(COPD)诊治指南(2007年修订版)》和中医辨证标准收治肺气虚、脾气虚、肾气虚组COPD稳定期的患者和正常对照组各30例,分析4组的红细胞免疫(RBC-C3bRR、RBC-I-CR)差异。结果 COPD组RBC-C3bRR和RBC-ICR与正常对照组比较,差异具有显著的统计学意义;在肺气虚、脾气虚、肾气虚3个证型中,差异也有显著的统计学意义,肺气虚组→脾气虚组→肾气虚组RBC-C3bRR逐步减少,RBC-ICR逐步增高。结论 RBC-C3bRR、RBC-ICR可作为COPD稳定期患者辨证分型、病情预后、疗效判定的参考指标。 Objective To study the correlation between erythrocyte immune function and TCM syn- dromes of chronic obstructive pulmonary disease (COPD) patients at stable stage. Methods COPD patients with lung Qi deficiency syndrome, spleen Qi deficiency syndrome and kidney Qi deficiency syndrome at stable stage were selected according to the diagnosis and treatment guidelines of COPD and criteria of TCM syndrome differentiation, and healthy people as control. The differences of red blood cell immune (RBC-C3bRR, RBC-ICR) among various syndromes were analyzed. Results There were significant differences in RBC- C3bRR rate and RBC-ICR rate between COPD patients and healthy people. There were also significant differences in RBC-C3bRR rate and RBC-ICR rate among three syndromes, the RBC-C3bRR rate of lung Qi deficiency syndrome was the highest and that of kidney Qi deficiency syndrome was the lowest, and the RBC-ICR rate of kidney Qi deficiency syndrome was the highest and that of lung Qi deficiency syndrome was the lowest. Conclusion Combined determination of RBC-C3bRR and RBC-ICR can be regarded as the reference index for the syndrome differentiation, prognosis and therapeutic effect judging of COPD patients at stable stage.
出处 《福建中医药大学学报》 2012年第1期1-3,共3页 Journal of Fujian College of Traditional Chinese Medicine
基金 福建省科技厅资助课题(2009R10007-4)
关键词 慢性阻塞性肺疾病 中医证型 红细胞C3b受体花环率 红细胞免疫复合物受体花环率 chronic obstructive pulmonary disease TCM syndromes RBC-C3bRR RBC-ICR
  • 相关文献

参考文献7

  • 1SIEGEL I. The red cell immune system[J]. Lancet, 1981,2 (8246) :55.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8251
  • 3国家食品药品监督管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:226-230.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则第二辑[S].北京:中国医药科技出版社,1995:100.
  • 5戚晓昆,朱克,刘洁晓,张凤英.多发性硬化和格林-巴利综合征患者红细胞免疫的研究[J].中华内科杂志,1996,35(8):517-519. 被引量:3
  • 6FEARON D T. Indentification of the membrane glycoprote that is the C3b recepter of the huwan erythrocyte,polymouphonulear leukocyte,B-lymphocyte end monocyte[J]. J Eap Med, 1980, 152 ( 1 ) : 20-30.
  • 7FERRINI S. Re-targeting of human lymphocyte expressing the T-cell receptor gamma/delta to ovariao carcinoma cell by the use of bispecific monoclonal antibodies[J]. Int J Cancer, 1989,44(2) :245-250.

二级参考文献10

共引文献8394

同被引文献101

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部